Hair Restoration News since 1997
Cell Therapy – Maksim Plikus, professor of developmental and cell biology at the University of California, and chief scientific officer of hair biotech company Amplifica, uncovered the role of a potent signaling molecule called SCUBE3. It is speculated that by activating stem cells present in people’s scalps, SCUBE3 triggers the follicles to promote rapid hair growth. The team is hoping to start human trials by late 2023 or early 2024.
Click Amplifica SCUBE3 baldness research for details.
Events – World Congress for Hair Research Melbourne 2022. The 12th World Congress for Hair Research will be held at the Melbourne Convention & Exhibition Centre, Australia, from 18 – 21 November 2022. The congress will focus on emerging treatments and research for hair disease. Among some of the keynote speakers are: Prof Angela Christiano; Dr. George Cotsarelis; Prof Mike Archer; Prof Steven Kossard; Prof Rodney Sinclair; Professor Ralf Paus and more.
Click World Congress for Hair Research Melbourne 2022 for details.
Cell Therapy – RepliCel long anticipated RCH-01 cell therapy hair regeneration treatment encountered a roadblock. In December 2021, RepliCel officially announced termination of its license agreement with cosmeticeutical giant Shiseido due to ongoing dispute. There is no word as to how this may unfold and whether their RCH-01 hair regeneration treatment for androgenetic alopecia or pattern baldness will be available in the near future, if at all.
Click RepliCel terminates agreement with Shiseido on its RCH-01 hair regeneration product for details.
Cell therapy – Platelet Rich Plasma (PRP) vs Platelet Rich Fibrin (PRF). Why do some doctors believe that PRF is superiod to PRP in treating hair loss and thinning hair? Both Platelet Rich Plasma (PRP) and Platelet Rich Fibrin (PRF) are non invasive cell based therapies that use the patient’s own blood platelet as growth factors for healthy hair growth.
PRF is superior because it is spun at a lower speed which allows some of the white blood cells and stem cells to remain within the platelet layer that is collected for treatment purposes. Thus, there are more growth or healing factors within PRF. In addition, the lower spin speed causes less trauma to the individual cells of the blood and therefore allowing more stem cells or growth factors to remain in the final plasma. Another key difference between PRP and PRF is the concentration of the platelets.
Click Why Platelet Rich Fibrin (PRF) is superior to Platelet Rich Plasma (PRP) in treating hair loss to learn more.
Cell Therapy – San Diego based Stemson Therapeutics will potentially start its human hair regrowth trial in the UK. Stemson is one of the forerunners in the quest for a cure for hair loss. The company adopts a novel approach to hair restoration or hair regrowth using the patient’s own cells to generate new hair follicles. Latest news announcement suggests that Stemson may potentially set up its research and development as well as human trials in the UK.
Click Stemson targets UK for its human hair regrowth trial for details.
British “stem cell” treatment claims to reverse hair loss by about 30% to 40%. Doctors in the UK selling the new £2,000 per session “stem cell” procedure claim that it is the world’s first “cure for baldness”. It is reported that the procedure works by using a device called Rigenera Activa which can extract stem cells from fat, skin and hair. Click British stem cell treatment reverses hair loss by up to 40% for details.
In this much anticipated live stream interview, Drs. Marc Avram and Nicole Rogers interviewed Angela M. Christiano, PhD on the topic of 3D printing of scaffolding for human hair follicle neogenesis as a potential cure for hair loss. This live stream interview was part of the Norwood Lecture at the ISHRS 2020 World Congress taking place from October 17-25. Click Dr. Angela Christiano on 3D printing of scaffolding for human hair follicle neogensis to watch a recorded copy of the live stream.
The treatment name is HST-001, or Hair Stimulating Complex (HSC). It is intended to be a relatively safe, minimally invasive physician-administered treatment for hair loss. HSC is formulated to enrich growth factors including KGF, VEGF and follistatin, which are involved in signaling stem cells in the body and have been shown to be important in hair formation and the stimulation of resting hair follicles. Click Histogen announces completion of dosing milestone in its trial for male pattern baldness for details about this announcement.
South Korea Hair Regrowth Peptide PTD-DBM – latest updates for PTD-DBM hair regeneration peptide. News broke out in our forum a few years ago and we now have confirmation that CK Biotechnology is official in human trials with PTD-DBM, a peptide that can regrow hair by functioning as a CXXC5 inhibitor according to the research. Click Korea Hair Regrowth Peptide PTD-DBM to find out availability timeline for this exciting topical treatment for hair loss.
In a study supported by the National Institute of Health, researchers from North Carolina State University have identified a microRNA molecule that could promote hair regeneration and new hair growth bypassing the need for hair stem cells. Trial results show almost 90% hair regrowth in as little as 15 days. Click North Carolina State University microRNA hair regeneration for details.
